Roën et al.
(x3), 23.5, 22.0, 21.2 (x2), 17.9, 17.7, -4.1, -4.4, -4.5 (x2). Anal.
Calcd for C53H74Br2O16Si2: C, 53.81; H, 6.30. Found: C, 53.82; H,
6.41.
°C; [R]D ) -12.3 (c 0.3, CHCl3); MS (FAB) Calcd for
C60H86Br2O16Si2Na (M + Na)+ 1278, Found 1278; 1H NMR
(CDCl3) δ 7.81 (d, J ) 8.8 Hz, 2H), 7.79 (d, J ) 8.8 Hz, 2H),
7.54 (d, J ) 8.5 Hz, 2H), 7.50 (d, J ) 8.5 Hz, 2H), 7.20 (d, J )
8.6 Hz, 2H), 6.84 (d, J ) 8.5 Hz, 2H), 5.33 (t, J ) 9.3 Hz, 1H),
5.00 (d, J ) 8.5 Hz, 1H), 4.78 (d, J ) 8.7 Hz, 1H), 4.70 (d, J )
10.9 Hz, 1H), 4.61 (d, J ) 7.9 Hz, 1H), 4.43 (dd, J ) 3.6 and 12.1
Hz, 1H), 4.40 (d, J ) 10.9 Hz, 1H), 4.34 (d, J ) 8.0 Hz, 1H), 4.29
(dd, J ) 4.9 and 12.1 Hz, 1H), 3.96 (dd, J ) 1.3 and 11.8 Hz,
1H), 3.93 (t, J ) 8.9 Hz, 1H), 3.76 (s, 3H), 3.75 (m, 1H), 3.71 (t,
J ) 8.9 Hz, 1H), 3.62 (dd, J ) 6.7 and 11.8 Hz, 1H), 3.40 (m,
2H), 3.26 (t, J ) 9.2 Hz, 1H), 2.25 (m, 1H), 2.06 (s, 3H), 2.05 (s,
3H), 1.97 (m, 1H), 1.63 (m, 3H), 1.26 (m, 2H), 0.92 (m, 6H), 0.87
(s, 9H), 0.81 (d, J ) 6.8 Hz, 3H), 0.72 (s, 9H), 0.04 (s, 6H), -0.02
(s, 3H), -0.20 (s, 3H); 13C NMR (CDCl3) δ 169.2, 168.9, 165.3,
164.3, 159.2, 131.8–128.2, 113.8 (x2), 101.1, 97.9, 78.9, 77.0, 75.6,
75.2, 74.7, 74.1, 73.8, 73.0, 72.3, 71.6, 68.4, 63.5, 55.2, 47.7, 40.5,
34.3, 31.4, 25.7 (x3), 25.4 (x3), 25.2, 23.3, 22.3, 21.3 (x2), 21.0
(x2), 17.8, 17.7, 16.4, -4.1, -4.3, -4.5 (x2). Anal. Calcd for
C60H86Br2O16Si2: C, 56.30; H, 6.80. Found: C, 56.38; H, 6.81.
tert-Butyl 2-O-Acetyl-6-O-{2-O-acetyl-4,6-bis-O-(4-bromoben-
zoyl)-3-O-[tert-butyl(dimethyl)silyl]-ꢀ-D-glucopyranosyl}-3-O-
[tert-butyl(dimethyl)silyl]-4-O-(4-methoxybenzyl)-ꢀ-D-glucopy-
ranoside (16). Following the general procedure, 151 mg (0.14
mmol) of compound 9 was treated with 1 mL of tert-butanol to
give, after column chromatography (n-hexane/EtOAc, 9:1), 84 mg
(0.07 mmol) of compound 16 in a 56% yield as an anomer mixture
(ꢀ/R ) 1.4:1): TLC Rf ) 0.5 (n-hexane/EtOAc, 7.5:2.5); colorless
syrup; [R]D ) +7.2 (c 0.4, CHCl3); MS (FAB) Calcd for
C54H76Br2O16Si2Na (M + Na)+ 1219, Found 1219; 1H NMR
(CDCl3) δ 7.82 (d, J ) 8.6 Hz, 2H), 7.75 (d, J ) 8.5 Hz, 2H),
7.54 (d, J ) 8.6 Hz, 2H), 7.48 (d, J ) 8.5 Hz, 2H), 7.18 (d, J )
8.6 Hz, 2H), 6.82 (d, J ) 8.6 Hz, 2H), 5.33 (t, J ) 9.3 Hz, 1H),
5.01 (t, J ) 8.5 Hz, 1H), 4.78 (dd, J ) 8.2 and 9.1 Hz, 1H), 4.68
(d, J ) 10.9 Hz, 1H), 4.55 (d, J ) 8.0 Hz, 1H), 4.43 (d, J ) 7.9
Hz, 1H), 4.40 (d, J ) 10.9 Hz, 1H), 4.41 (dd, J ) 3.2 and 12.1 Hz,
1H), 4.32 (dd, J ) 4.8 and 12.1 Hz, 1H), 3.98 (dd, J ) 1.0 and 9.6
Hz, 1H), 3.93 (t, J ) 8.9 Hz, 1H), 3.81 (m, 1H), 3.76 (s, 3H), 3.74
(t, J ) 9.0 Hz, 1H), 3.52 (dd, J ) 7.5 and 10.7 Hz, 1H), 3.47 (m,
1H), 3.18 (t, J ) 9.1 Hz, 1H), 2.06 (s, 6H), 1.21 (s, 9H), 0.90 (s,
9H), 0.71 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H), -0.02 (s, 3H), -0.21
(s, 3H); 13C NMR (CDCl3) δ 168.9 (x2), 165.4, 164.4, 159.3,
131.8–128.4, 113.8 (x2), 100.8, 95.5, 78.7, 75.7, 75.3, 75.0, 74.7,
74.1, 73.3, 73.1, 71.7, 67.6, 63.6, 55.3, 28.7 (x3), 25.8 (x3), 25.4
(x3), 21.4 (x2), 17.7 (x2), -4.0, -4.2, -4.4 (x2). Anal. Calcd for
C54H76Br2O16Si2: C, 54.20; H, 6.40. Found: C, 54.34; H, 6.17.
Methyl 2-O-Acetyl-6-O-{2-O-acetyl-4,6-bis-O-(4-bromoben-
zoyl)-3-O-[tert-butyl(dimethyl)silyl]-ꢀ-D-glucopyranosyl}-3-O-
[tert-butyl(dimethyl)silyl]-ꢀ-D-glucopyranoside (17). Following
the general procedure for debenzylation, 82.3 mg (0.07 mmol) of
compound 11 yielded 67.8 mg (0.06 mmol) of compound 17 (91%):
TLC Rf ) 0.3 (n-hexane/EtOAc, 7:3); mp ) 82.0-82.7 °C; [R]D
) +1.0 (c 1.0, CHCl3); MS (FAB) Calcd for C43H63Br2O15Si2 (M
+ 1)+ 1057, Found 1057; 1H NMR (CDCl3) δ 7.83 (d, J ) 8.5 Hz,
4H), 7.55 (d, J ) 8.3 Hz, 2H), 7.53 (d, J ) 8.3 Hz, 2H), 5.36 (t,
J ) 9.4 Hz, 1H), 5.03 (dd, J ) 8.2 and 8.8 Hz, 1H), 4.80 (dd, J )
8.3 and 9.1 Hz, 1H), 4.61 (d, J ) 8.0 Hz, 1H), 4.50 (dd, J ) 3.4
and 12.2 Hz, 1H), 4.35 (dd, J ) 4.6 and 12.2 Hz, 1H), 4.21 (d, J
) 8.0 Hz, 1H), 4.09 (dd, J ) 2.2 and 10.8 Hz, 1H), 4.00 (t, J )
9.0 Hz, 1H), 3.88 (m, 1H), 3.77 (m, 1H), 3.61 (t, J ) 9.1 Hz, 1H),
3.46 (s, 3H), 3.46–3.42 (m, 2H), 2.43 (s, 1H), 2.10 (s, 3H), 2.09
(s, 3H), 0.85 (s, 9H), 0.71 (s, 9H), 0.09 (s, 3H), 0.05 (s, 3H), -0.01
(s, 3H), -0.20 (s, 3H); 13C NMR (CDCl3) δ 169.5, 169.3, 165.5,
164.3, 131.9–128.4, 101.9, 101.1, 75.8, 74.4, 73.5, 73.4, 73.0, 72.4,
72.0, 71.9, 68.8, 63.2, 56.7, 25.7 (x3), 25.4 (x3), 21.3 (x2), 18.0,
17.7, -4.2, -4.5 (x2), -4.7. Anal. Calcd for C43H62Br2O15Si2: C,
49.90; H, 6.04. Found: C, 49.99; H, 6.00.
Cyclohexyl 2-O-Acetyl-6-O-{2-O-acetyl-4,6-bis-O-(4-bromoben-
zoyl)-3-O-[tert-butyl(dimethyl)silyl]-ꢀ-D-glucopyranosyl}-3-O-
[tert-butyl(dimethyl)silyl]-4-O-(4-methoxybenzyl)-ꢀ-D-glucopy-
ranoside (13). Following the general procedure for disaccharides,
140 mg (0.13 mmol) of compound 9 was treated with 1 mL of
cyclohexanol to lead, after column chromatography (n-hexane/
EtOAc, 9:1), to 96 mg of compound 13 (0.08 mmol) in a 60%
yield: TLC Rf ) 0.6 (n-hexane/EtOAc, 7:3); mp ) 172.4-174.3
°C; [R]D ) +3.5 (c 1.1, CHCl3); MS (FAB) Calcd for
C56H78Br2O16Si2Na (M + Na)+: 1245. Found 1245; 1H NMR
(CDCl3) δ 7.82 (d, J ) 8.6 Hz, 2H), 7.76 (d, J ) 8.5 Hz, 2H),
7.54 (d, J ) 8.6 Hz, 2H), 7.48 (d, J ) 8.5 Hz, 2H), 7.19 (d, J )
8.6 Hz, 2H), 6.82 (d, J ) 8.6 Hz, 2H), 5.33 (t, J ) 9.3 Hz, 1H),
5.01 (t, J ) 8.6 Hz, 1H), 4.81 (dd, J ) 8.1 and 9.3 Hz, 1H), 4.69
(d, J ) 10.9 Hz, 1H), 4.58 (d, J ) 8.0 Hz, 1H), 4.43 (dd, J ) 3.6
and 12.1 Hz, 1H), 4.40 (d, J ) 11.1 Hz, 1H), 4.35 (d, J ) 8.1 Hz,
1H), 4.33 (dd, J ) 4.7 and 12.1 Hz, 1H), 3.99 (dd, J ) 1.6 and
11.0 Hz, 1H), 3.94 (t, J ) 8.9 Hz, 1H), 3.80 (m, 1H), 3.77 (s, 3H),
3.73 (t, J ) 9.0 Hz, 1H), 3.62 (m, 1H), 3.55 (dd, J ) 7.5 and 11.0
Hz, 1H), 3.46 (m, 1H), 3.21 (t, J ) 9.2 Hz, 1H), 2.07 (s, 3H), 2.06
(s, 3H), 1.90–1.20 (m, 10H), 0.88 (s, 9H), 0.71 (s, 9H), 0.05 (s,
3H), 0.04 (s, 3H), -0.02 (s, 3H), -0.20 (s, 3H); 13C NMR (CDCl3)
δ 169.2 (s), 169.0 (s), 165.4, 164.3, 159.3, 131.8–128.4, 113.8 (x2),
100.8, 99.4, 78.9, 77.0, 75.3, 75.1, 74.7, 74.0, 73.4, 73.0, 72.3, 71.7,
67.5, 63.6, 55.2, 33.4, 31.5, 29.7, 25.8 (x3), 25.5, 25.4 (x3), 23.7,
23.4, 21.3, 21.2, 17.9, 17.7, -4.0, -4.4 (x2), -4.5. Anal. Calcd
for C56H78Br2O16Si2: C, 53.99; H, 6.43. Found: C, 53.83; H, 6.58.
(+)-Menthyl 2-O-Acetyl-6-O-{2-O-acetyl-4,6-bis-O-(4-bro-
mobenzoyl)-3-O-[tert-butyl(dimethyl)silyl]-ꢀ-D-glucopyranosyl}-
3-O-[tert-butyl(dimethyl)silyl]-4-O-(4-methoxybenzyl)-ꢀ-D-glu-
copyranoside (14). Following the general procedure, 136 mg (0.13
mmol) of compound 9 was treated with 100 mg of (+)-menthol
(0.64 mmol, 5 equiv) to provide, after column chromatography (n-
hexane/EtOAc, 9.5:0.5), 65 mg of compound 14 (0.05 mmol) in
40% yield as an anomer mixture (ꢀ/R ) 1.2:1): TLC Rf ) 0.6 (n-
hexane/EtOAc, 7:3); mp ) 173.1-174.9 °C; [R]D ) +11.0 (c 0.5,
CHCl3); MS (FAB) Calcd for C60H86Br2O16Si2Na (M + Na)+ 1278,
1
Found 1278; H NMR (CDCl3) δ 7.80 (d, J ) 8.7 Hz, 2H), 7.78
(d, J ) 8.5 Hz, 2H), 7.54 (d, J ) 8.5 Hz, 2H), 7.50 (d, J ) 8.5 Hz,
2H), 7.19 (d, J ) 8.5 Hz, 2H), 6.83 (d, J ) 8.6 Hz, 2H), 5.34 (t,
J ) 9.3 Hz, 1H), 5.02 (d, J ) 8.5 Hz, 1H), 4.84 (d, J ) 8.6 Hz,
1H), 4.67 (d, J ) 10.9 Hz, 1H), 4.66 (d, J ) 7.8 Hz, 1H), 4.44 (d,
J ) 10.9 Hz, 1H), 4.43 (dd, J ) 3.6 and 12.2 Hz, 1H), 4.31 (d, J
) 7.8 Hz, 1H), 4.29 (dd, J ) 4.9 and 12.2 Hz, 1H), 3.94 (t, J )
8.9 Hz, 1H), 3.91 (dd, J ) 1.0 and 11.6 Hz, 1H), 3.79 (m, 1H),
3.77 (s, 3H), 3.69 (t, J ) 9.0 Hz, 1H), 3.67 (dd, J ) 6.8 and 11.6
Hz, 1H), 3.45 (m, 1H), 3.25 (m, 1H), 3.22 (t, J ) 9.2 Hz, 1H),
2.11 (m, 1H), 2.09 (s, 3H), 2.07 (m, 1H), 2.05 (s, 3H), 1.61 (m,
2H), 1.25 (m, 1H), 1.11 (m, 1H), 0.97 (d, J ) 6.5 Hz, 3H), 0.90
(d, J ) 6.5 Hz, 3H), 0.88 (s, 9H), 0.75 (d, J ) 6.9 Hz, 3H), 0.71
(s, 9H), 0.04 (s, 3H), 0.04 (s, 3H), -0.02 (s, 3H), -0.22 (s, 3H);
13C NMR (CDCl3) δ 169.2, 168.9, 165.3, 164.3, 159.2, 131.8–128.3,
113.8 (x2), 102.0, 100.8, 80.8, 78.8, 75.7, 75.1, 74.7, 74.3, 73.6,
73.1, 72.3, 71.7, 67.2, 63.5, 55.2, 48.5, 43.3, 34.1, 31.9, 25.7 (x3),
25.3 (x3), 24.6, 22.7, 22.5, 21.4, 21.3 (x2), 17.8, 17.7, 14.0, -4.1,
-4.4, -4.5, -4.6. Anal. Calcd for C60H86Br2O16Si2: C, 56.30; H,
6.80. Found: C, 56.27; H, 7.01.
(-)-Menthyl 2-O-Acetyl-6-O-{2-O-acetyl-4,6-bis-O-(4-bro-
mobenzoyl)-3-O-[tert-butyl(dimethyl)silyl]-ꢀ-D-glucopyranosyl}-
3-O-[tert-butyl(dimethyl)silyl]-4-O-(4-methoxybenzyl)-ꢀ-D-glu-
copyranoside (15). Following the general procedure for preparation
of disaccharides, 140 mg (0.13 mmol) of compound 9 was treated
with 100 mg of (-)-menthol (0.64 mmol, 5 equiv) to give, after
column chromatography (n-hexane/EtOAc, 9.5:0.5), 87 mg (0.07
mmol) of compound 15 in 52% yield as an anomer mixture (ꢀ/R
) 1.5:1): TLC Rf ) 0.5 (n-hexane/EtOAc, 8:2); mp ) 171.3-173.6
iso-Propyl 2-O-Acetyl-6-O-{2-O-acetyl-4,6-bis-O-(4-bromoben-
zoyl)-3-O-[tert-butyl(dimethyl)silyl]-ꢀ-D-glucopyranosyl}-3-O-
3360 J. Org. Chem. Vol. 73, No. 9, 2008